PR
Papa Rao Vegi
About Papa Rao Vegi
Data last updated:
Papa Rao Vegi is a Director at Steel City Pharmaceuticals Pvt Ltd (since 2008), Managing Director at Gajuwaka Pharmaceuticals Private Limited (since 2014) and Director at Saimadhuri Chits (Gajuwaka) Private Limited (since 2014), and holds 3 more current directorships. The companies operate in Pharma, Financial Services and Steel. The 4 current companies with reported revenue have a combined latest revenue of ₹26.70 Cr; the largest is Steel City Pharmaceuticals Pvt Ltd at ₹15.63 Cr (FY 2022). Earlier, Papa Rao Vegi was a Director at Ukkunagar Chits Private Limited (2004–2012) and Director at Gajuwaka Chitfunds Private Limited (2005–2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Steel City Pharmaceuticals Pvt Ltd U24239AP1993PTC016799 | Director | 30 Sep 2008 | 1993 | ₹15.63 Cr (FY 2022) | Active |
| Gajuwaka Pharmaceuticals Private Limited U24239AP2002PTC038342 | Managing Director | 14 Mar 2014 | 2002 | ₹10.79 Cr (FY 2023) | Active |
| Saimadhuri Chits (Gajuwaka) Private Limited U65991AP2014PTC095022 | Director | 08 Aug 2014 | 2014 | ₹27.4 Lakh (FY 2017) | Active |
| Simhagiri Developers Private Limited U27109AP1977PTC002219 | Director | 31 Mar 2017 | 1977 | ₹1 Lakh (FY 2020) | Active |
| Saimadhuri Properties Private Limited U45309AP2017PTC105304 | Director | 03 Mar 2017 | 2017 | Active | |
| Designated Partner | 18 Aug 2015 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ukkunagar Chits Private Limited U65992AP1998PTC029565 | Director | 30 Sep 2004 | 1998 | ₹48.7 Lakh (FY 2025) | Active |
| Gajuwaka Chitfunds Private Limited U65992AP2000PTC034984 | Director | 07 Aug 2005 | 2000 | ₹92.7 Lakh (FY 2017) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Papa Rao Vegi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Papa Rao Vegi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Papa Rao Vegi
Papa Rao Vegi currently holds 6 directorships: Steel City Pharmaceuticals Pvt Ltd (Director, since 30 Sep 2008, revenue ₹15.63 Cr (FY 2022)); Gajuwaka Pharmaceuticals Private Limited (Managing Director, since 14 Mar 2014, revenue ₹10.79 Cr (FY 2023)); Saimadhuri Chits (Gajuwaka) Private Limited (Director, since 08 Aug 2014, revenue ₹27.4 Lakh (FY 2017)); Simhagiri Developers Private Limited (Director, since 31 Mar 2017, revenue ₹1 Lakh (FY 2020)); Saimadhuri Properties Private Limited (Director, since 03 Mar 2017); and 1 more.
Papa Rao Vegi was first appointed on 30 Sep 2004 as Director at Ukkunagar Chits Private Limited. The most recent appointment on record is 31 Mar 2017 at Simhagiri Developers Private Limited.
The 4 current companies of Papa Rao Vegi that report revenue have a combined latest revenue of ₹26.70 Cr: Steel City Pharmaceuticals Pvt Ltd ₹15.63 Cr (FY 2022); Gajuwaka Pharmaceuticals Private Limited ₹10.79 Cr (FY 2023); Saimadhuri Chits (Gajuwaka) Private Limited ₹27.4 Lakh (FY 2017); Simhagiri Developers Private Limited ₹1 Lakh (FY 2020).
Papa Rao Vegi held 2 earlier board appointments: Ukkunagar Chits Private Limited (Director, 30 Sep 2004 to 25 Mar 2012); Gajuwaka Chitfunds Private Limited (Director, 07 Aug 2005 to 01 Apr 2014).
The current boards of Papa Rao Vegi's companies include Narasimharaju Datlavenkata (Steel City Pharmaceuticals Pvt Ltd), Rama Chandra Rao Vemulapalli (Steel City Pharmaceuticals Pvt Ltd), Satyanarayana Chaparala (Steel City Pharmaceuticals Pvt Ltd), Surya Sita Rama Raju Kakarlapudi (Steel City Pharmaceuticals Pvt Ltd), Thirupathi Rao Bommi (Steel City Pharmaceuticals Pvt Ltd), Veeru Naidu Manthini (Steel City Pharmaceuticals Pvt Ltd), among others.